Tag

Cancer Detection

All articles tagged with #cancer detection

Diabetes-alert dog Barkley uncovers cancer clues in Idaho
health15 days ago

Diabetes-alert dog Barkley uncovers cancer clues in Idaho

An Idaho teen with Type 1 diabetes relies on Barkley, a diabetes-alert dog trained to sniff for low and high blood sugar and alert with a ball reward. During training, Barkley unexpectedly began growling at people with cancer—first at a patient with skin cancer recurrence and later at another cancer patient (one case involved a pregnant woman)—suggesting the dog’s nose may detect cancer scents. While studies note dogs can be trained to identify cancer, more research is needed. Barkley’s alerts help Jaylin manage her condition and have made him a clinic favorite, giving the family peace of mind.

Life’s faint glow: a potential new signal for health and disease
science28 days ago

Life’s faint glow: a potential new signal for health and disease

All living beings emit ultraweak biophotons detectable with sensitive cameras, a signal linked to metabolism and oxidative stress. Researchers hope these faint photons could reveal health status, distinguish cancerous from healthy cells, monitor disease progression, and possibly enable noninvasive diagnostics or light-based therapies, though evidence for photon-based cellular communication remains controversial and the field is still maturing.

MethylScan: A Low-Cost Blood Test for Early, Multi-Disease Detection
biotechnology4 months ago

MethylScan: A Low-Cost Blood Test for Early, Multi-Disease Detection

UCLA researchers report MethylScan, a simple, affordable test that analyzes DNA methylation in circulating cell-free DNA to detect multiple cancers and liver diseases, and to indicate tissue of origin and organ health. In 1,061 samples, it achieved about 98% specificity, ~63% cancer detection across stages (~55% for early-stage) and ~80% detection of liver cancers in high‑risk groups, with a sequencing depth of ~300× costing under $20 per test as costs fall. By reducing background DNA, it functions as a system-wide health monitor, though larger prospective studies are needed to confirm real-world effectiveness.

Major UK Trial Undermines Promise of Galleri Multi-Cancer Blood Test
health6 months ago

Major UK Trial Undermines Promise of Galleri Multi-Cancer Blood Test

In a large UK trial of 142,000 adults over three years, Grail's Galleri multi-cancer blood test did not reduce late-stage cancers (stages 3–4), though researchers noted a secondary signal of fewer Stage 4 cancers; the test remains FDA-unapproved, is sold with limited insurer coverage, and Medicare coverage remains under legislative review.

Grail's Galleri multi-cancer test misses primary endpoint in NHS study, fueling skepticism
biotech6 months ago

Grail's Galleri multi-cancer test misses primary endpoint in NHS study, fueling skepticism

Grail's Galleri blood test for early cancer detection failed to meet its primary endpoint in a large NHS-backed study, renewing questions about its clinical utility despite some detected benefits. Grail reported selling 185,000 tests in 2025 for $136.8 million, and its stock fell about 47% after hours following the setback.

Advances in Blood Tests Promise Early Detection and Improved Cancer Outcomes
health8 months ago

Advances in Blood Tests Promise Early Detection and Improved Cancer Outcomes

New blood tests capable of detecting multiple cancers simultaneously show promise for earlier diagnosis and improved cancer care, but currently face challenges such as high false-positive rates, lack of standardization, and integration into clinical practice. Experts believe these tests will improve over time and could revolutionize cancer diagnostics, though more research and validation are needed.